UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases 94,768 Shares of Cardinal Health, Inc. (NYSE:CAH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 4.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,321,797 shares of the company's stock after purchasing an additional 94,768 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.96% of Cardinal Health worth $274,599,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cyrus J. Lawrence LLC purchased a new stake in Cardinal Health during the 4th quarter valued at approximately $26,000. Promus Capital LLC purchased a new position in Cardinal Health during the fourth quarter valued at $30,000. Bellwether Advisors LLC purchased a new position in Cardinal Health during the fourth quarter valued at $32,000. Lee Danner & Bass Inc. bought a new stake in Cardinal Health in the 4th quarter valued at $35,000. Finally, Itau Unibanco Holding S.A. purchased a new stake in Cardinal Health in the 4th quarter worth $36,000. Institutional investors own 87.17% of the company's stock.

Cardinal Health Stock Up 0.7%

CAH traded up $1.11 during trading hours on Tuesday, reaching $153.86. 378,258 shares of the company's stock traded hands, compared to its average volume of 2,224,512. The firm has a 50-day moving average price of $139.99 and a 200 day moving average price of $129.49. The firm has a market capitalization of $36.72 billion, a PE ratio of 28.68, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $156.44.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The firm had revenue of $54.88 billion during the quarter, compared to analyst estimates of $55.33 billion. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The business's revenue was up .0% on a year-over-year basis. During the same period in the previous year, the firm earned $2.08 earnings per share. Equities analysts predict that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a $0.5107 dividend. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 dividend on an annualized basis and a yield of 1.33%. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health's dividend payout ratio is currently 31.83%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on CAH. JPMorgan Chase & Co. raised their price objective on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a research report on Tuesday, February 4th. Wall Street Zen upgraded Cardinal Health from a "buy" rating to a "strong-buy" rating in a report on Monday, May 5th. Jefferies Financial Group raised Cardinal Health from a "hold" rating to a "buy" rating and upped their price objective for the stock from $140.00 to $150.00 in a report on Wednesday, February 5th. Mizuho increased their target price on Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a research report on Monday, March 31st. Finally, Morgan Stanley boosted their price target on shares of Cardinal Health from $142.00 to $166.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Four investment analysts have rated the stock with a hold rating, ten have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat.com, Cardinal Health presently has an average rating of "Moderate Buy" and a consensus price target of $146.43.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.